Translational Neuroscience Toward New Therapies
Experts from academia and industry discuss how to create a new, more effective translational neuroscience drawing on novel technology and recent discoveries. Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Cambridge
The MIT Press
2015
|
| Series: | Strüngmann Forum Reports
17 |
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_78538 | ||
| 005 | 20220221 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220221s2015 xx |||||o ||| 0|eng d | ||
| 020 | |a mitpress/9780262029865.001.0001 | ||
| 020 | |a 9780262329859 | ||
| 020 | |a 9780262029865 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.7551/mitpress/9780262029865.001.0001 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MJN |2 bicssc | |
| 072 | 7 | |a MMH |2 bicssc | |
| 100 | 1 | |a Nikolich, Karoly |4 edt | |
| 700 | 1 | |a Hyman, Steven E. |4 edt | |
| 700 | 1 | |a Nikolich, Karoly |4 oth | |
| 700 | 1 | |a Hyman, Steven E. |4 oth | |
| 245 | 1 | 0 | |a Translational Neuroscience |b Toward New Therapies |
| 260 | |a Cambridge |b The MIT Press |c 2015 | ||
| 300 | |a 1 electronic resource (320 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Strüngmann Forum Reports |v 17 | |
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Experts from academia and industry discuss how to create a new, more effective translational neuroscience drawing on novel technology and recent discoveries. Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience. The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use. They conclude with a conceptual roadmap for an effective and credible translational neuroscience-one informed by a disease-focused knowledge base and clinical experience. Contributors Tobias M. Böckers, Thomas Bourgeron, Karl Broich, Nils Brose, Bruce N. Cuthbert, Ilka Diester, Gül Dölen, Guoping Feng, Richard Frackowiak, Raquel E. Gur, Stephan Heckers, Franz Hefti, David M. Holtzman, Steven E. Hyman, Nancy Ip, Cynthia Joyce, Tobias Kaiser, Edward H. Koo, Walter J. Koroshetz, Katja S. Kroker, Robert C. Malenka, Isabelle Mansuy, Eliezer, Masliah, Yuan Mei, Andreas Meyer-Lindenberg, Lennart Mucke, Pierluigi Nicotera, Karoly Nikolich, Michael J. Owen, Menelas N. Pangalos, Alvaro Pascual-Leone, Joel S. Perlmutter, Trevor W. Robbins, Lee L. Rubin, Akira Sawa, Mareike Schnaars, Bernd Sommer, Maria Grazia Spillantini, Laura Spinney, Matthew W. State, Marius Wernig | ||
| 540 | |a Creative Commons |f by-nc-nd/4.0 |2 cc |4 http://creativecommons.org/licenses/by-nc-nd/4.0 | ||
| 546 | |a English | ||
| 650 | 7 | |a Neurology & clinical neurophysiology |2 bicssc | |
| 650 | 7 | |a Psychiatry |2 bicssc | |
| 653 | |a Strüngmann Forum Reports | ||
| 653 | |a translational neuroscience | ||
| 653 | |a diagnostics | ||
| 653 | |a biomarkers | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://doi.org/10.7551/mitpress/9780262029865.001.0001 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78538 |7 0 |z DOAB: description of the publication |